Gilead Sciences makes takeover approach to Forty Seven: Bloomberg News [Reuters]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: Reuters
Gilead Sciences makes takeover approach to Forty Seven: Bloomberg News (Reuters) - Drugmaker Gilead Sciences Inc ( GILD.O ) has approached cancer therapy company Forty Seven Inc ( FTSV.O ) with a takeover offer, Bloomberg News reported on Thursday, citing people familiar with the matter. Gilead and Forty Seven are discussing a number of options, including a partnership, according to the report. ( bloom.bg/3cdiZkY ) Forty Seven has received interest from other potential suitors as well, though no deal has been finalized, Bloomberg News reported. Shares of Forty Seven rose 23.4% to $60.10 after market, while Gilead gained 1.6%. Both the companies did not immediately respond to a Reuters request for comment.
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Autoimmune Hepatitis Diagnosis and Treatment Market Size to Reach USD 19.15 Bn by 2032 [Yahoo! Finance]Yahoo! Finance
- Winn Awards Help Physicians Solve Healthcare Disparities [Yahoo! Finance]Yahoo! Finance
- Top Pictet Fund Manager Sees Biotech Stocks Joining AI-Euphoria [Yahoo! Finance]Yahoo! Finance
- Top Pictet Fund Manager Sees Biotech Stocks Joining AI-Euphoria [BNN Bloomberg (Canada)]BNN Bloomberg
- Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
GILD
Earnings
- 2/6/24 - Miss
GILD
Sec Filings
- 3/22/24 - Form 8-K
- 3/18/24 - Form PRE
- 3/14/24 - Form 8-K
- GILD's page on the SEC website